HEXO launches medical cannabis products in Israel
July 09 2020 - 6:30AM
HEXO Corp (TSX: HEXO; NYSE: HEXO) (“HEXO” or the “Company”) is
proud to announce that it has launched medical cannabis products in
Israel through a 24-month agreement with leading Israeli medical
cannabis company, Breath of Life International Ltd. (“BOL”).
“For the first time, HEXO’s high-quality medical
cannabis is available to medical patients outside of Canada,”
said Sebastien St-Louis, CEO and co-founder of HEXO. “Launching the
HEXO brand in Israel is a testament to the continued work we are
doing to expand our international footprint and find new markets
for our award-winning products.”
HEXO completed the first shipment of 493 kilograms amidst
tightening international borders, a significant reduction in air
cargo availability, and increased safety measures within its
facilities due to the global COVID-19 pandemic. Today, medical
patients in Israel are able to access some of HEXO’s bestselling
flower products packaged in a 10-gram format and designed
exclusively for the Israeli market, including bilingual (English
and Hebrew) packaging and labels.
“We are proud to introduce HEXO’s premium indoor medical
cannabis products into the Israeli market,” said Hugo Goldman,
BOL’s CFO and interim CEO. The products are already receiving
positive feedback from both patients and retailers, and we are
looking forward to continuing to expand our strategic relationship
with HEXO in Israel.”
BOL is a leading, GMP certified, Israeli medical cannabis
company, with an established distribution network through
pharmacies including Super-Pharm, Israel’s largest pharmacy
retailer with 258 locations. The agreement concluded after
collaboration between BOL and HEXO to adapt HEXO products to meet
the specific needs of Israel’s medical cannabis patients, all while
strictly adhering to regulatory requirements under Israel’s Medical
Cannabis regulatory body.
About HEXO Corp
HEXO Corp is an award-winning consumer packaged goods cannabis
company that creates and distributes innovative products to serve
the global cannabis market. The Company serves the Canadian
adult-use markets under its HEXO Cannabis, Up Cannabis and Original
Stash brands, and the medical market under HEXO medical cannabis.
For more information please
visit hexocorp.com.
Forward-Looking Statements
This press release contains forward-looking information and
forward-looking statements within the meaning of applicable
securities laws (“forward-looking statements”). Forward-looking
statements are based on certain expectations and assumptions and
are subject to known and unknown risks and uncertainties and other
factors that could cause actual events, results, performance and
achievements to differ materially from those anticipated in these
forward-looking statements. Forward-looking statements should not
be read as guarantees of future performance or results. A more
complete discussion of the risks and uncertainties facing the
Company appears in the Company’s Annual Information Form and other
continuous disclosure filings, which are available on SEDAR
at www.sedar.com and EDGAR
at www.sec.gov. Readers are cautioned not to
place undue reliance on these forward-looking statements, which
speak only as of the date of this press release. The Company
disclaims any intention or obligation, except to the extent
required by law, to update or revise any forward-looking statements
as a result of new information or future events, or for any other
reason.
Investor
Relations:invest@HEXO.com www.hexocorp.com
Media Relations:(819)
317-0526media@hexo.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/ccbd0c67-b02e-4277-b066-7302c4cd3ea4
HEXO (NASDAQ:HEXO)
Historical Stock Chart
From Aug 2024 to Sep 2024
HEXO (NASDAQ:HEXO)
Historical Stock Chart
From Sep 2023 to Sep 2024